[34 links to videos on vaccines. And a list of 110 Books about the dangers of medical injections.]

Read rest of original story here:

January 26, 2021 by: Lance D Johnson
(Natural News) Robert F. Kennedy Jr. and the Baum Hedlund Law Firm from Los Angeles, California have filed their fifth lawsuit against Merck, taking on the drug company’s dangerous and deceptive Gardasil vaccine, and standing up for innocent young people who have been disabled by the vaccine. The law firm is taking on Merck and the grander kangaroo court system, which has shielded vaccine makers from liability for over thirty years.

Read rest of original story here:

September 22, 2020 by: Cassie B,
(Natural News) A lawsuit was filed last week against pharmaceutical firm Merck on behalf of a young man who was injured by their HPV vaccine Gardasil. The suit, which was filed by Baum Hedlund Aristei & Goldman, seeks punitive damages for their negligence along with liability for failure to warn and a manufacturing defect, common law fraud, breach of warranty and other charges.

Read rest of original story here:

February 7, 2020, By Arjun Walia
In Brief

   The Facts: A new study raises concerns and questions about the effectiveness of the HPV and if it really plays any role at all in preventing cervical cancer.

   Reflect On: Are vaccines as effective as they're marketed to be?

A new study published in The Royal Society of Medicine is one of multiple studies over the years that has emerged questioning the efficacy of the HPV vaccine. The researchers conducted an appraisal of published phase 2 and 3 efficacy trials in relation to the prevention of cervical cancer and their analysis showed “the trials themselves generated significant uncertainties undermining claims of efficacy” in the data they used. The researchers emphasized that “it is still uncertain whether human papillomavirus (HPV) vaccination prevents cervical cancer as trials were not designed to detect this outcome, which takes decades to develop.” The researchers point out that the trials used to test the vaccine may have “overestimated” the efficacy of the vaccine.

Read rest of original story here:

February 05, 2020 By Robert F. Kennedy, Jr., CHD Chairman
SEC filings reveal that Merck’s Vaccine Division President Julie Gerberding sold over half her Merck shares in January for $9.1 Million. That transaction followed a spate of bad news for Merck’s flagship Gardasil vaccine.

"It is still uncertain whether human papillomavirus (HPV) vaccination prevents cervical cancer as trials were not designed to detect this outcome.

Last month, Cancer Research UK announced an alarming 54% rise in cervical cancer among 24-29-year-olds, the first generation to receive the HPV jabs. The following day, the Journal of the Royal Society of Medicine published a withering critique of Gardasil’s crooked clinical trials, “It is still uncertain whether human papillomavirus (HPV) vaccination prevents cervical cancer as trials were not designed to detect this outcome.”

Read rest of original story here: Update March 06, 2020
Top Health Official Cashes in on Merck Stock
https://articles.mercola.com